HIV 1 GAG AND ENV PROTEINS IN VIRUS ASSEMBLY AND INFECTION
HIV 1 GAG AND ENV PROTEINS IN VIRUS ASSEMBLY AND INFECTION
批准号:
6099088
负责人:
Eric O Freed
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
点击翻译按钮获取中文摘要
英文摘要
To characterize functions of the HIV-1 Gag matrix
(MA) protein and define domains involved in these functions, we
have introduced over 80 single and double amino acid mutations
throughout MA. Biological and biochemical analysis identified
classes of mutations which: i) impaired Gag membrane binding or
myristylation, ii) blocked Env incorporation into virions, iii)
blocked virus assembly, iv) impaired virus entry, or v) redirected
assembly from the plasma membrane to cytoplasmic compartments.
During the course of these studies, viral revertants of all classes of
mutations were obtained and characterized. The majority of
second-site changes identified in the MA region of these revertant
viruses were located distantly from the original mutations in the
primary sequence. When introduced into MA in the presence of the
original mutations, these second-site changes compensated for the
defects caused by the original substitutions, suggesting a direct or
functional interaction between the pairs of distantly-located amino
acids. The second-site changes were also introduced in the context
of wild-type MA and some of them caused defects in HIV-1
replication, suggesting structural or functional interdependency
between the second-site and original mutations. The mutational
analysis and characterization of revertants further our
understanding of the relationship between MA structure and
function, and enable us to delineate the role of MA in the HIV-1 life
cycle. Sequence comparison of a number of primate lentivirus
isolates reveals a very high degree of sequence conservation at MA
amino acid 20 (Leu). Mutations at this position, in particular Lys
and Arg substitutions, delayed or blocked virus replication in T-cell
lines, primary PBMC, and human macrophages. Biochemical
analyses revealed that the residue 20 mutations did not affect virus
assembly and release, Env incorporation into virions, exogenous RT
activity, or RNA encapsidation. However, a defect early in the virus
life cycle was observed in single cycle (MAGI) infectivity assays,
which demonstrated a 10-fold reduction in virus infectivity. Kinetic
analyses of reverse transcription by PCR using a range of primers at
early time points post-infection in both primary macrophages and
T-cell lines indicated that viral DNA synthesis was impaired in cells
infected with the mutant virus. Intriguingly, viral DNA synthesis
was diminished in endogenous RT assays. A viral revertant
maintained the position 20 change and acquired second-site changes
at residues 73 and 82. Interestingly, activity of the revertant virus in
the endogenous RT assay was restored to wild-type levels.
Lentiviruses, including HIV-1, possess transmembrane envelope
(Env) glycoproteins with unusually long cytoplasmic tails. A
prominent structural feature of the HIV-1 cytoplasmic domain is
the presence of two predicted a-helices in the central (a-helix 2) and
C-terminal (a-helix 1) portions of the cytoplasmic domain. To
characterize these domains, we have introduced a number of
truncations, deletions, and single and double amino acid
substitution mutations throughout both a-helical domains. The
effects on Env expression, Env incorporation into virions, virus
infectivity in MAGI cells, virus replication in T-cells, and syncytium
formation has been assessed. The results indicate that the gp41
cytoplasmic tail a-helical domains play an important role in Env
incorporation and virus infectivity, and identify specific functional
determinants within these domains. We also observed that several
mutations in gp41 a-helix 2 markedly impair Gag processing, and
that this defective Gag processing is relieved by a matrix (MA)
mutation which blocks Env incorporation into virions. This
phenomenon supports the hypothesis that MA and gp41 interact
during Gag and Env transport and virus assembly.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Assembly and Release of HIV-1 and Other Retroviruses
-
批准号:7338694
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Eric O Freed
-
依托单位:
HIV 1 GAG AND ENV PROTEINS IN VIRUS ASSEMBLY AND INFECTION
-
批准号:6431674
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Eric O Freed
-
依托单位:
HIV 1 Gag And Env Proteins In Virus Assembly And Infecti
-
批准号:6506962
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Eric O Freed
-
依托单位:
Hiv 1 Gag And Env Proteins In Virus Assembly/ Infection
-
批准号:6808838
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Eric O Freed
-
依托单位:
HIV 1 GAG AND ENV PROTEINS IN VIRUS ASSEMBLY AND INFECTION
-
批准号:6160765
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Eric O Freed
-
依托单位:
HIV 1 GAG AND ENV PROTEINS IN VIRUS ASSEMBLY AND INFECTION
-
批准号:6288970
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Eric O Freed
-
依托单位:
Assembly and Release of HIV-1 and Other Retroviruses
-
批准号:7292903
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Eric O Freed
-
依托单位:
Hiv 1 Gag And Env Proteins In Virus Assembly And Infecti
-
批准号:6669707
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Eric O Freed
-
依托单位:
海外基金